Physician

Christopher S Lynn, MD

According to 2025 Medicare claims, Christopher Lynn, MD (NPI: 1386759603) practices neurology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is HATTIESBURG CLINIC PA (NPI: 1740213446; TIN: 640507572) and primary practice location at 39402-3262. Lynn is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880) and Health Leaders Network of Mississippi LLC (ACO ID: A5148), participating under the MSSP model.

Lynn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 980 traditional Medicare patients, billed 203,099 HCPCS/CPT codes, and received $1,038,378 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 4,860 prescription claims across 560 beneficiaries totaling $759,562 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2020 DME data shows 12 claims. Open Payments data shows 216 records totaling $4,438. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $654,909 and ending at $1,038,378. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,139	24,809	$654,909
2016	1,220	27,628	$741,328
2017	1,156	28,276	$713,570
2018	1,143	26,883	$726,682
2019	1,201	30,154	$899,674
2020	982	23,873	$586,278
2021	954	30,959	$631,144
2022	941	29,502	$625,040
2023	964	61,044	$701,612
2024	980	203,099	$1,038,378

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	401	3,826	$643,701
2016	459	3,833	$725,310
2017	438	3,585	$788,800
2018	441	3,421	$910,923
2019	484	3,771	$689,799
2020	496	4,296	$712,493
2021	529	4,783	$657,742
2022	535	4,571	$740,028
2023	545	4,592	$727,128
2024	560	4,860	$759,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$853
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	144	147	$140
93880	Ultrasound of both sides of head and neck blood flow	219	220	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	436	746	$80
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	97	147	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	484	843	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	25	126	$165,336
Austedo	Deutetrabenazine	14	420	$133,199
Vumerity	Diroximel Fumarate	12	360	$112,137
Aptiom	Eslicarbazepine Acetate	21	630	$42,876
Aimovig Autoinjector	Erenumab-Aooe	46	1,718	$40,339

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	216	$4,438	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher S. Lynn, MD?

Tedicare shows public-source Medicare data for Christopher S. Lynn, MD (NPI 1386759603), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher S. Lynn, MD have ACO affiliation data?

Christopher S. Lynn, MD is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880) and Health Leaders Network of Mississippi LLC (MSSP, ACO ID A5148).

What billing organization is linked to Christopher S. Lynn, MD?

Christopher S. Lynn, MD is linked to HATTIESBURG CLINIC PA (billing NPI 1740213446) in the available physician profile data.

Does Christopher S. Lynn, MD have Open Payments data?

Christopher S. Lynn, MD has 216 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.